Correction: Belimumab for Treating Active Autoantibody‑Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Detalles Bibliográficos
Autores principales: Otten, Thomas, Riemsma, Rob, Wijnen, Ben, Armstrong, Nigel, Stirk, Lisa, Gordon, Caroline, Ramaekers, Bram, Kleijnen, Jos, Joore, Manuela, Grimm, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570210/
https://www.ncbi.nlm.nih.gov/pubmed/37665503
http://dx.doi.org/10.1007/s40273-023-01315-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570210/
https://www.ncbi.nlm.nih.gov/pubmed/37665503
http://dx.doi.org/10.1007/s40273-023-01315-1

Ejemplares similares